Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 1
2016 1
2017 2
2018 2
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.
Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM; PRECISION Trial Investigators. Nissen SE, et al. N Engl J Med. 2016 Dec 29;375(26):2519-29. doi: 10.1056/NEJMoa1611593. Epub 2016 Nov 13. N Engl J Med. 2016. PMID: 27959716 Free article. Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
Microscopic polyangiitis secondary to silica exposure.
Vega Miranda J, Pinto Peñaranda LF, Márquez Hernández JD, Velásquez Franco CJ. Vega Miranda J, et al. Among authors: pinto penaranda lf. Reumatol Clin. 2014 May-Jun;10(3):180-2. doi: 10.1016/j.reuma.2013.04.009. Epub 2013 Jul 23. Reumatol Clin. 2014. PMID: 23886979 Free article. English, Spanish.
Antiphospholipid antibodies, steroid dose, arterial hypertension, relapses, and late-onset predict organ damage in a population of Colombian patients with systemic lupus erythematosus.
Pinto-Peñaranda LF, Muñoz-Grajales C, Echeverri Garcia AF, Velásquez-Franco CJ, Mesa-Navas MA, Zuluaga Quintero M, Herrera-Uribe S, Márquez-Hernández JD. Pinto-Peñaranda LF, et al. Clin Rheumatol. 2018 Apr;37(4):949-954. doi: 10.1007/s10067-017-3927-8. Epub 2017 Dec 4. Clin Rheumatol. 2018. PMID: 29204758
Concordance and correlation of activity indices in patients with rheumatoid arthritis in northwestern Colombia: A cross-sectional study.
Restrepo-Correa R, Rodríguez-Padilla LM, Zapata-Castellanos AL, Ocampo A, García JJ, Muñoz-Grajales C, Pinto-Peñaranda LF, Márquez-Hernández JD, Mesa-Navas MA, Velásquez-Franco CJ. Restrepo-Correa R, et al. Among authors: pinto penaranda lf. Int J Rheum Dis. 2018 Nov;21(11):1946-1954. doi: 10.1111/1756-185X.13227. Epub 2017 Nov 19. Int J Rheum Dis. 2018. PMID: 29152874